Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2025

The unique capabilities of PASCAL Precision system

Presenter: Gennaro Giustino

October 28, 2025

Presentation Interventional Complications 2025

Case 3: BEV Embolized

Presenter: Gennaro Giustino

July 10, 2025

Presentation NY Valves 2025

First-in-Human Percutaneous Transseptal Retrieveal of Embolized Transcatheter Valve in the Left Ventricle (RETRIEVE)

Presenter: Gennaro Giustino

June 27, 2025

Presentation NY Valves 2025

PASCAL Precision Case Review

Presenter: Gennaro Giustino

June 25, 2025

Presentation Miami Valves 2025

Valve Embolization in the Ventricle Managed Percutaneously

Presenter: Gennaro Giustino

January 30, 2025

Presentation TCT 2024

TCT 167: Transjugular Transcatheter Tricuspid Valve Replacement With the EVOQUE System

Presenter: Gennaro Giustino

October 29, 2024

Presentation NY Valves 2024

Outcomes in Patients With Severe Mitral Annular Calcifications and High-Risk for Left Ventricular Outflow Tract Obstruction Referred for Mitral Valve Therapies

Presenter: Gennaro Giustino

June 05, 2024

Presentation TCT 2023

TCT 263: Percutaneous Coronary Intervention Risk Stratification: SYNTAX Score Versus Complex PCI Score

Presenter: GENNARO GIUSTINO

October 25, 2023

Presentation TCT 2021

Ischemic Risk Prediction and Stratification After PCI: The State of the Art in 2021

Presenter: Gennaro Giustino

November 05, 2021

Presentation TVT 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presenter: Gennaro Giustino

July 20, 2021

Presentation TVT 2020

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Presenter: Gennaro Giustino

June 21, 2020

Presentation TCT 2019

Case Example: A Complex Left Main Bifurcation

Presenter: Gennaro Giustino

September 25, 2019

Presentation TCT 2018

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, Gennaro Giustino

September 21, 2018

Presentation TCT 2017

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Presenter: John A. Bittl, Freek W.A. Verheugt, Gennaro Giustino

October 30, 2017

Presentation TCT 2016

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Gennaro Giustino

November 01, 2016

Presentation TCT 2016

Optimal DAPT Duration After Complex or Complicated PCI: A Pooled Analysis

Presenter: John A. Bittl, Daniel I. Simon, Gennaro Giustino

October 30, 2016

Presentation TCT 2016

ACS Case Presentation: Where Pharmacotherapy Failed

Presenter: C. Michael Gibson, Daniel I. Simon, Gennaro Giustino

October 30, 2016

Presentation

Efficacy and Safety of DAPT After Complex PCI

Presenter: Gennaro Giustino

September 01, 2016

Presentation TCT 2015

DAPT Duration Case 2: An Elderly Patient With CKD and Left Main Bifurcation Stenting Postdischarge Course

Presenter: John A. Bittl, Gary L. Schaer, Gennaro Giustino

October 12, 2015

Presentation TCT 2015

DAPT Duration Case 1: An Elderly Patient With CKD and Left Main Bifurcation Stenting In-Hospital Course

Presenter: John A. Bittl, Gary L. Schaer, Gennaro Giustino

October 12, 2015

Advertisement

The unique capabilities of PASCAL Precision system

Case 3: BEV Embolized

First-in-Human Percutaneous Transseptal Retrieveal of Embolized Transcatheter Valve in the Left Ventricle (RETRIEVE)

PASCAL Precision Case Review

Valve Embolization in the Ventricle Managed Percutaneously

TCT 167: Transjugular Transcatheter Tricuspid Valve Replacement With the EVOQUE System

Outcomes in Patients With Severe Mitral Annular Calcifications and High-Risk for Left Ventricular Outflow Tract Obstruction Referred for Mitral Valve Therapies

TCT 263: Percutaneous Coronary Intervention Risk Stratification: SYNTAX Score Versus Complex PCI Score

Ischemic Risk Prediction and Stratification After PCI: The State of the Art in 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Case Example: A Complex Left Main Bifurcation

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Optimal DAPT Duration After Complex or Complicated PCI: A Pooled Analysis

ACS Case Presentation: Where Pharmacotherapy Failed

Efficacy and Safety of DAPT After Complex PCI

DAPT Duration Case 2: An Elderly Patient With CKD and Left Main Bifurcation Stenting Postdischarge Course

DAPT Duration Case 1: An Elderly Patient With CKD and Left Main Bifurcation Stenting In-Hospital Course

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content